Effectiveness of Noninvasive Phrenic Nerve Neuromodulation in Shoulder Pain and Hepatobiliary Visceral Comorbidity.

Launched by UNIVERSITY OF SEVILLE · Mar 5, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment method called noninvasive phrenic nerve neuromodulation for people experiencing shoulder pain, especially those who may also have liver or gallbladder issues. Researchers believe that certain problems in the liver or gallbladder can cause pain that feels like it’s coming from the shoulder, due to connections in the nervous system. The goal is to see if treating the phrenic nerve can help relieve this pain in patients who have both shoulder pain and hepatobiliary (liver and gallbladder) conditions.

To participate in the trial, you need to be between 18 and 64 years old and have right shoulder pain along with a liver or gallbladder issue that might be linked to your pain. If you qualify and choose to join, you will be part of a study that aims to improve understanding and treatment of this type of pain. It’s important to know that some people may not be eligible, such as those with certain chronic diseases or severe psychiatric conditions. If you have questions or are interested in participating, the research team will provide more information and support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Over 18 years of age.
• • Subjects presenting right shoulder pain at the time of enrollment in the study.
• • Presentation of a hepatobiliary visceral disorder that may justify the visceral etiology of the pain.
• • That they agree to participate in the project by signing the informed consent form.
• Exclusion Criteria:
• • Patients with chronic pain due to other diseases such as malignant disease.
• • Patients with rheumatic diseases.
• • Cutaneous infection in the area of pain.
• • Disease of neurological, traumatic, oncologic, or infectious origin that rules out the visceral origin of the pain.
• • Uncooperative subject.
• • Severe psychiatric disease.
• • Loss of cognitive capacity.
• • Contraindication to electrotherapy.